Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7


Within-Host Evolution of Burkholderia pseudomallei during Chronic Infection of Seven Australasian Cystic Fibrosis Patients.

Viberg LT, Sarovich DS, Kidd TJ, Geake JB, Bell SC, Currie BJ, Price EP.

MBio. 2017 Apr 11;8(2). pii: e00356-17. doi: 10.1128/mBio.00356-17.


Long-term safety of tiotropium delivered by Respimat® SoftMist™ Inhaler: patient selection and special considerations.

Tan CK, Say GQ, Geake JB.

Ther Clin Risk Manag. 2016 Sep 21;12:1433-1444. eCollection 2016. Review.


The changing prevalence of pulmonary infection in adults with cystic fibrosis: A longitudinal analysis.

Ramsay KA, Sandhu H, Geake JB, Ballard E, O'Rourke P, Wainwright CE, Reid DW, Kidd TJ, Bell SC.

J Cyst Fibros. 2017 Jan;16(1):70-77. doi: 10.1016/j.jcf.2016.07.010. Epub 2016 Aug 8.


An international, multicentre evaluation and description of Burkholderia pseudomallei infection in cystic fibrosis.

Geake JB, Reid DW, Currie BJ, Bell SC; MelioidCF Investigators, Bright-Thomas R, Dewar J, Holden S, Simmonds N, Gyi K, Kenna D, Waters V, Jackson M, O'Sullivan B, Taccetti G, Kolbe J, O'Carroll M, Campbell D, Jaksic M, Radhakrishna N, Kidd TJ, Flight W.

BMC Pulm Med. 2015 Oct 9;15:116. doi: 10.1186/s12890-015-0109-9.


Indacaterol, a once-daily beta2-agonist, versus twice-daily beta₂-agonists or placebo for chronic obstructive pulmonary disease.

Geake JB, Dabscheck EJ, Wood-Baker R, Cates CJ.

Cochrane Database Syst Rev. 2015 Jan 10;1:CD010139. doi: 10.1002/14651858.CD010139.pub2. Review.


Sudden death in a young male with a recent pneumothorax: a case report.

Geake JB, Ritchey DM, Burke J, Halliday A, Wood-Baker R, Maguire G.

Eur Respir Rev. 2014 Mar 1;23(131):145-7. doi: 10.1183/09059180.00004913. No abstract available.


Acute spontaneously resolving pulmonary vasculitis: a case report.

Geake JB, Maguire G.

Case Reports Immunol. 2012;2012:706838. doi: 10.1155/2012/706838. Epub 2012 Nov 20.

Supplemental Content

Loading ...
Support Center